Bio-Rad Laboratories, Inc. Liquidation Value
BIO
Other
Cash & Equivalents
$529.80M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $529.80M
Total Obligations: -$1.91B
$-1.38B
Per share: $-50.61
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $529.80M
AR: $460.60M
Total Obligations: -$1.91B
$-919.30M
Per share: $-33.72
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $529.80M
AR: $460.60M
Inventory: $740.70M
Total Obligations: -$1.91B
$-178.60M
Per share: $-6.55
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-1.38B | $-50.61 |
| Liquid Liquidation Value | $-919.30M | $-33.72 |
| Operating Liquidation Value | $-178.60M | $-6.55 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $529.80M |
| Accounts Receivable | $460.60M |
| Inventory | $740.70M |
| Current Liabilities | $517.00M |
| Long-term Debt | $1.20B |
| Op. Lease Liability | $181.80M |
| Finance Lease | $9.20M |
| Shares Outstanding | 27.3M |
Explore all 323 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $529.80M | $460.60M | $740.70M | $129.00M | $517.00M | $1.20B | $181.80M | $9.20M |
| 2025-09-30 | $395.80M | $464.70M | $783.20M | $128.80M | $522.30M | $1.20B | $192.60M | $9.30M |
| 2025-06-30 | $369.30M | $469.90M | $798.80M | $139.30M | $548.90M | $1.20B | $204.10M | $9.40M |
| 2025-03-31 | $521.40M | $424.70M | $790.10M | $137.90M | $506.60M | $1.20B | $167.60M | $9.50M |
| 2024-12-31 | $488.10M | $452.50M | $760.00M | $122.30M | $467.80M | $1.20B | $173.10M | $9.60M |
▼ Community Notes